Shari Wiseman
Shari Wiseman is an American neuroscientist and the editor in chief of Nature Neuroscience.
Education
Wiseman has two PhDs from Yale University and undertook postdoctoral research at the Beth Israel-Deaconess Medical Center where she worked on animal models of autism spectrum disorders.[1] After that, she undertook postdoctoral training at Tufts University where she focused on the regulation of GABAB receptors by excitotoxic stimuli.[1]
Career
She has worked at Nature Neuroscience since 2017, as an associate editor, becoming the editor in chief in 2021.[1][2]
Selected publications
- Senescence in Down syndrome NPCs, Nature Neuroscience, 2022 Feb;25(2):131. doi: 10.1038/s41593-022-01016-6. PMID 35132233
References
- "About the Editors | Nature Neuroscience". www.nature.com. Retrieved 2022-04-04.
- "SEMINAR - Dr. Shari Wiseman - Associate Editor, Nature Neuroscience | The Douglas Research Centre". douglas.research.mcgill.ca. Retrieved 2022-04-06.
- "Twitter biography". Twitter. Retrieved 2022-04-06.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.